Strokes can be classified as either ischemic or hemorrhagic, where an ischemic stroke is characterized by failure in proper blood supply to a part of brain due to blockage (due to blood clots or arthrosclerosis) created in the blood vessel. These blood clots have the ability of travelling to brain either from heart (cardioemblic stroke) or from another artery (artery-to-artery embolization).Acute ischemic strokes can be caused by building up fatty materials along the walls of artery, breaking off atheroma from the artery wall and getting stuck in a smaller artery, blood clots which break loose from heart valves also known as embolus, inflammation or infection to an artery, drugs like cocaine and amphetamines which narrow the blood vessels and sudden drop in blood pressure. According to the WHO,each year 15 million people suffer from stroke worldwide. The global acute ischemic stroke treatment market can be segmented on the basis of drug treatmentsand surgical procedures.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/acute-ischemic-stroke-treatment.html
Acute ischemic stroke (AIS) treatment marketis driven by aging population which has higher incidence of AIS.Other drivers of this market include recent launch of novel new generation drugs, growing research investments andincreasing prominence of telemedicine.A major growth avenue in this market opened with the launch of Desmoteplase, a novel next-generation thrombolytic, which has an extended therapeutic time window when compared with the current standard of care.
North America is considered to be the largest AIS treatment market because of highest prevalence and incidence of AIS and comparatively high AIS therapy cost in this region. In the United States, AIS is the third leading cause of death as well as one of the leading causes of disability. Europe is second largest market for AIS treatment as the major countries such as the U.K., Germany, Spain and Italy have the highest prevalence and incidence of AIS from this region. Asia-Pacific market is considered to be the most attractive market for AIS. Some of the key players of this market include Bayer, Bristol-Myers Squibb, BoehringerIngelheim, Lundbeck, ThromboGenics, Vernalis and Others.
This research report analyzes this market depending on its market segments, major geographies, and current market trends.
Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
More Reports On Pharmaceutical Market: – http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
90 State Street,
Albany NY – 12207
Browse Market Researche Report:-